CinCor Pharma Inc. Made Big Gain
Wed, Jul 13, 2022 at 08:33 PM
CinCor Pharma Inc. (CINC:NASDAQ) shot up at $24.65, a gain of 21.1%. On Wed, Jul 13, 2022, CINC:NASDAQ touched a New 2-Week High of $24.65. From Thu, Jun 30, 2022, the stock recorded 62.50% Up Days and 66.67% Green Days
About CinCor Pharma Inc. (CINC:NASDAQ)
CinCor Pharma Inc is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases.
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 47.15%
- ironSource Ltd. Class A (IS:NYSE), 47.09%
- TDH Holdings, Inc. (PETZ:NASDAQ), 42.23%
- NuCana plc (NCNA:NASDAQ), 41.4%
- Gossamer Bio, Inc. (GOSS:NASDAQ), 31.9%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 31.48%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 24.34%
- The OLB Group, Inc. (OLB:NASDAQ), 23.86%
- Velo3D Inc. (VLD:NYSE), 22.22%
- CinCor Pharma Inc. (CINC:NASDAQ), 21.13%